IL6 and metabolic syndrome: Several studies have reported that inflammatory biomarkers (e.g. Interleukin-6, Tumor Necrosis Factor-alpha and C-reactive protein) were significantly increased in adult patients with obesity associated with MetS and that their increment was positively correlated with the severity of MetS, making their evaluation a powerful diagnostic tool, especially during adulthood [13–19].